IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
3,367,324
3,367,324
3,215,360
2,706,655
2,406,908
Cost of revenue
1,362,986
1,362,986
1,325,928
1,135,615
1,041,359
Gross profit
2,004,338
2,004,338
1,889,432
1,571,040
1,365,549
Operating expenses
Research development
254,820
254,820
161,009
141,249
133,193
Selling general and administrative
850,753
850,753
796,395
735,267
679,510
Total operating expenses
1,105,573
1,105,573
957,404
876,516
812,703
Operating income or loss
898,765
898,765
932,028
694,524
552,846
Interest expense
39,858
38,793
29,374
32,539
30,628
Income before tax
859,972
859,972
902,654
661,985
522,218
Income tax expense
180,883
180,883
157,810
79,854
94,426
Income from continuing operations
679,089
679,089
744,844
582,131
427,792
Net income
679,089
679,089
744,845
581,776
427,720
Net income available to common shareholders
679,089
679,089
744,845
581,776
427,720
Basic EPS
-
8.12
8.74
6.82
4.97
Diluted EPS
-
8.03
8.60
6.71
4.89
Basic average shares
-
83,623
85,200
85,342
86,115
Diluted average shares
-
84,600
86,572
86,722
87,542
EBITDA
-
898,765
932,028
694,524
552,846